Pioneer Investment Management Inc. held its stake in Endo International PLC (NASDAQ:ENDP) during the second quarter, Holdings Channel reports. The firm owned 28,618 shares of the company’s stock at the end of the second quarter. Pioneer Investment Management Inc.’s holdings in Endo International PLC were worth $320,000 as of its most recent SEC filing.

A number of other hedge funds have also recently added to or reduced their stakes in the company. HL Financial Services LLC boosted its stake in Endo International PLC by 1.0% in the second quarter. HL Financial Services LLC now owns 52,800 shares of the company’s stock valued at $590,000 after buying an additional 500 shares during the last quarter. Diamond Hill Capital Management Inc. purchased a new stake in Endo International PLC during the second quarter valued at $5,454,000. Russell Investments Group Ltd. boosted its stake in Endo International PLC by 20.9% in the second quarter. Russell Investments Group Ltd. now owns 325,860 shares of the company’s stock valued at $3,640,000 after buying an additional 56,407 shares during the last quarter. Oakbrook Investments LLC boosted its stake in Endo International PLC by 8.2% in the second quarter. Oakbrook Investments LLC now owns 17,100 shares of the company’s stock valued at $191,000 after buying an additional 1,300 shares during the last quarter. Finally, Nisa Investment Advisors LLC purchased a new stake in Endo International PLC during the second quarter valued at $507,000. 92.27% of the stock is owned by institutional investors and hedge funds.

Endo International PLC (ENDP) opened at 8.14 on Wednesday. The stock has a 50 day moving average price of $10.70 and a 200 day moving average price of $11.49. The company’s market cap is $1.82 billion. Endo International PLC has a 52 week low of $7.41 and a 52 week high of $24.93.

Endo International PLC (NASDAQ:ENDP) last issued its quarterly earnings data on Tuesday, August 8th. The company reported $0.93 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.74 by $0.19. Endo International PLC had a positive return on equity of 37.58% and a negative net margin of 126.93%. The company had revenue of $875.73 million for the quarter, compared to the consensus estimate of $832.66 million. During the same quarter last year, the business posted $0.86 earnings per share. The firm’s revenue was down 4.9% compared to the same quarter last year. On average, equities analysts forecast that Endo International PLC will post $3.52 earnings per share for the current year.

COPYRIGHT VIOLATION WARNING: “Pioneer Investment Management Inc. Holds Position in Endo International PLC (ENDP)” was first reported by Watch List News and is the sole property of of Watch List News. If you are viewing this piece on another website, it was stolen and reposted in violation of US and international copyright legislation. The legal version of this piece can be accessed at https://www.watchlistnews.com/pioneer-investment-management-inc-holds-position-in-endo-international-plc-endp/1493530.html.

ENDP has been the subject of several analyst reports. Canaccord Genuity set a $10.00 price objective on Endo International PLC and gave the company a “hold” rating in a report on Monday. BMO Capital Markets reaffirmed a “market perform” rating and issued a $11.00 price objective (down from $15.00) on shares of Endo International PLC in a report on Friday, August 11th. Morgan Stanley dropped their price objective on Endo International PLC from $12.00 to $8.00 and set an “equal weight” rating for the company in a report on Thursday, August 10th. Cowen and Company reaffirmed a “hold” rating and issued a $16.00 price objective on shares of Endo International PLC in a report on Thursday, August 10th. Finally, Citigroup Inc. reaffirmed a “neutral” rating and issued a $11.00 price objective (down from $14.00) on shares of Endo International PLC in a report on Thursday, August 10th. Three research analysts have rated the stock with a sell rating, sixteen have issued a hold rating and five have issued a buy rating to the company. Endo International PLC presently has an average rating of “Hold” and a consensus price target of $14.75.

In other Endo International PLC news, COO Terrance J. Coughlin acquired 20,000 shares of the stock in a transaction that occurred on Thursday, August 10th. The shares were bought at an average price of $7.70 per share, for a total transaction of $154,000.00. Following the completion of the transaction, the chief operating officer now owns 181,369 shares of the company’s stock, valued at approximately $1,396,541.30. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, CFO Blaise Coleman acquired 6,500 shares of the stock in a transaction that occurred on Tuesday, August 15th. The stock was acquired at an average price of $7.89 per share, for a total transaction of $51,285.00. Following the transaction, the chief financial officer now directly owns 13,729 shares of the company’s stock, valued at approximately $108,321.81. The disclosure for this purchase can be found here. Insiders purchased 36,000 shares of company stock worth $279,460 in the last quarter. 0.50% of the stock is currently owned by company insiders.

Endo International PLC Company Profile

Endo International PLC, formerly Endo Health Solutions Inc is a specialty healthcare solutions company focused on branded and generic pharmaceuticals, devices and services. The Company has a portfolio of branded pharmaceuticals that includes brands, such as Lidoderm, Opana ER, Voltaren Gel, Percocet, Frova, Supprelin LA, Vantas, Valstar and Fortesta Gel.

Want to see what other hedge funds are holding ENDP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Endo International PLC (NASDAQ:ENDP).

Institutional Ownership by Quarter for Endo International PLC (NASDAQ:ENDP)

Receive News & Ratings for Endo International PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Endo International PLC and related companies with Analyst Ratings Network's FREE daily email newsletter.